Using immune-compromised NOD/SCID/IL2Rγ null (NSG) mice, we examined whether subcutaneous co-injection of cancer cells and senescent cells depleted or not of G3BP1 affected tumor growth and proliferation in vivo. This evidence concerns the gene G3BP1 and cancer.